Table 6.
Results of cost-minimization analysis in 1,000 patients
| Third-Party Approach | OSUNet | MNC | STOP-BANG | |
|---|---|---|---|---|
|
OSA Prevalence = 0.49 | ||||
| Cost A: HST (US$) | 174,000 | 78,405 | 128,806 | 144,180 |
| Cost B: In-lab PSG (US$) | 333,483 | 157,659 | 104,027 | |
| Cost C: In-lab PSG for patients with negative HST (US$) | 309,570 | 64,794 | 172,783 | 215,979 |
| Total cost (US$) | 483,570 | 476,682 | 459,248 | 464,186 |
| Savings per 103 patients with prediction tool (US$) | 6,888 | 24,322 | 19,384 | |
|
OSA Prevalence = 0.20 | ||||
| Cost A: HST (US$) | 174,000 | 53,556 | 110,051 | 130,695 |
| Cost B: In-lab PSG (US$) | 420,170 | 223,087 | 151,069 | |
| Cost C: In-lab PSG for patients with negative HST (US$) | 485,600 | 101,637 | 271,032 | 338,791 |
| Total cost (US$) | 659,600 | 575,363 | 604,170 | 620,555 |
| Savings per 103 patients with prediction tool (US$) | 84,237 | 55,430 | 39,045 | |
Definition of abbreviations: AHI, apnea–hypopnea index; BMI, body mass index; HST, home sleep test; MNC, modified neck circumference; OSA, obstructive sleep apnea; PSG, polysomnography; STOP-BANG, Snoring, Tiredness, being Observed to stop breathing during sleep, high blood Pressure, Body mass index greater than 35 kg/m2, Age greater than 50 years, Neck circumference greater than 40 cm, and male Gender.